183 related articles for article (PubMed ID: 30527835)
1. Minimal difference in phenotype between adolescents and young adults with polycystic ovary syndrome.
Zore T; Lizneva D; Brakta S; Walker W; Suturina L; Azziz R
Fertil Steril; 2019 Feb; 111(2):389-396. PubMed ID: 30527835
[TBL] [Abstract][Full Text] [Related]
2. Menstrual dysfunction in polycystic ovary syndrome: association with dynamic state insulin resistance rather than hyperandrogenism.
Ezeh U; Ezeh C; Pisarska MD; Azziz R
Fertil Steril; 2021 Jun; 115(6):1557-1568. PubMed ID: 33602559
[TBL] [Abstract][Full Text] [Related]
3. Androgen dependence of hirsutism, acne, and alopecia in women: retrospective analysis of 228 patients investigated for hyperandrogenism.
Karrer-Voegeli S; Rey F; Reymond MJ; Meuwly JY; Gaillard RC; Gomez F
Medicine (Baltimore); 2009 Jan; 88(1):32-45. PubMed ID: 19352298
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of dermatologic manifestations and metabolic biomarkers in women with polycystic ovary syndrome in north China.
Feng JG; Guo Y; Ma LA; Xing J; Sun RF; Zhu W
J Cosmet Dermatol; 2018 Jun; 17(3):511-517. PubMed ID: 28940857
[TBL] [Abstract][Full Text] [Related]
5. Proposed criteria for the identification of polycystic ovary syndrome following menopause: An ancillary study of the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil).
Gabrielli L; de Almeida Mda C; Aquino EM
Maturitas; 2015 Jul; 81(3):398-405. PubMed ID: 26004079
[TBL] [Abstract][Full Text] [Related]
6. Clinical and metabolic characteristics of Turkish adolescents with polycystic ovary syndrome.
Ates S; Aydın S; Ozcan P; Soyman Z; Gokmen Karasu AF; Sevket O
J Obstet Gynaecol; 2018 Feb; 38(2):236-240. PubMed ID: 28920502
[TBL] [Abstract][Full Text] [Related]
7. Correlation of clinical and biochemical hyperandrogenism in Thai women with polycystic ovary syndrome.
Leerasiri P; Wongwananuruk T; Indhavivadhana S; Techatraisak K; Rattanachaiyanont M; Angsuwathana S
J Obstet Gynaecol Res; 2016 Jun; 42(6):678-83. PubMed ID: 26890011
[TBL] [Abstract][Full Text] [Related]
8. Clinical and biochemical presentations of polycystic ovary syndrome among obese and nonobese women.
Liou TH; Yang JH; Hsieh CH; Lee CY; Hsu CS; Hsu MI
Fertil Steril; 2009 Dec; 92(6):1960-5. PubMed ID: 18980763
[TBL] [Abstract][Full Text] [Related]
9. A simple screening approach for assessing community prevalence and phenotype of polycystic ovary syndrome in a semi-urban population in Sri Lanka.
Kumarapeli V; Seneviratne Rde A; Wijeyaratne CN; Yapa RM; Dodampahala SH
Am J Epidemiol; 2008 Aug; 168(3):321-8. PubMed ID: 18550559
[TBL] [Abstract][Full Text] [Related]
10. Impact of adrenal versus ovarian androgen ratio on signs and symptoms of polycystic ovarian syndrome.
Köşüş N; Köşüş A; Kamalak Z; Hızlı D; Turhan NÖ
Gynecol Endocrinol; 2012 Aug; 28(8):611-4. PubMed ID: 22296561
[TBL] [Abstract][Full Text] [Related]
11. How to Evaluate Acne in Reproductive-Age Women: An Epidemiological Study in Chinese Communities.
Wang YY; Li SW; Luo S; Qin L; Zeng X; Li L; Li XH
Biomed Res Int; 2019; 2019():6126808. PubMed ID: 30854398
[TBL] [Abstract][Full Text] [Related]
12. Defining Hyperandrogenism in Women With Polycystic Ovary Syndrome: A Challenging Perspective.
Pasquali R; Zanotti L; Fanelli F; Mezzullo M; Fazzini A; Morselli Labate AM; Repaci A; Ribichini D; Gambineri A
J Clin Endocrinol Metab; 2016 May; 101(5):2013-22. PubMed ID: 26964728
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous Findings and Systemic Associations in Women With Polycystic Ovary Syndrome.
Schmidt TH; Khanijow K; Cedars MI; Huddleston H; Pasch L; Wang ET; Lee J; Zane LT; Shinkai K
JAMA Dermatol; 2016 Apr; 152(4):391-8. PubMed ID: 26720591
[TBL] [Abstract][Full Text] [Related]
14. Ovarian morphology and prevalence of polycystic ovary syndrome in reproductive aged women with or without mild acne.
Kelekci KH; Kelekci S; Incki K; Ozdemir O; Yilmaz B
Int J Dermatol; 2010 Jul; 49(7):775-9. PubMed ID: 20618496
[TBL] [Abstract][Full Text] [Related]
15. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
[TBL] [Abstract][Full Text] [Related]
16. Normo- and hyperandrogenic women with polycystic ovary syndrome exhibit an adverse metabolic profile through life.
Pinola P; Puukka K; Piltonen TT; Puurunen J; Vanky E; Sundström-Poromaa I; Stener-Victorin E; Lindén Hirschberg A; Ravn P; Skovsager Andersen M; Glintborg D; Mellembakken JR; Ruokonen A; Tapanainen JS; Morin-Papunen LC
Fertil Steril; 2017 Mar; 107(3):788-795.e2. PubMed ID: 28089571
[TBL] [Abstract][Full Text] [Related]
17. Acne severity and the Global Acne Grading System in polycystic ovary syndrome.
Hacivelioglu S; Gungor AN; Gencer M; Uysal A; Hizli D; Koc E; Cosar E
Int J Gynaecol Obstet; 2013 Oct; 123(1):33-6. PubMed ID: 23948280
[TBL] [Abstract][Full Text] [Related]
18. PCOS Features and Steroid Profiles Among Young Adult Women with a History of Premature Adrenarche.
Tennilä J; Jääskeläinen J; Utriainen P; Voutilainen R; Häkkinen M; Auriola S; Morin-Papunen L; Liimatta J
J Clin Endocrinol Metab; 2021 Aug; 106(9):e3335-e3345. PubMed ID: 34060603
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study.
Knochenhauer ES; Key TJ; Kahsar-Miller M; Waggoner W; Boots LR; Azziz R
J Clin Endocrinol Metab; 1998 Sep; 83(9):3078-82. PubMed ID: 9745406
[TBL] [Abstract][Full Text] [Related]
20. Hormonal profiles and prevalence of polycystic ovary syndrome in women with acne.
Timpatanapong P; Rojanasakul A
J Dermatol; 1997 Apr; 24(4):223-9. PubMed ID: 9164062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]